Triglycerides
TG
Description
Triglycerides test checks the amount of triglycerides, a type of fat, in your blood. These fats store energy and play a key role in your body’s metabolism. Doctors use this test to evaluate heart health, assess the risk of heart disease, or monitor lipid levels, especially in people with conditions like diabetes or obesity. A blood sample is taken, usually after fasting, to check if your triglycerides are normal, borderline, or high. High triglycerides can raise the risk of heart disease, pancreatitis, or metabolic syndrome, while low levels might point to malnutrition or other issues. Based on your results, your doctor might suggest adjusting your diet, getting more exercise, or taking medication to lower your triglycerides. This test is particularly helpful if heart disease or high cholesterol runs in your family. Regular testing can help catch issues early and keep your heart in good shape.
Procedure
Invasive
Sample Type
Blood – Serum
Test Category
Lipids
Procedure Category
Blood Draw
Units
Milligrams per Deciliter | Millimoles per Liter
Test Groups
Basic Cardiovascular Group: This group includes fundamental tests targeting essential markers related to cardiovascular health, providing foundational insights into cholesterol levels, blood pressure, and other key factors. Basic Lipid Group: This group encompasses tests vital for evaluating lipid levels in the blood, aiding in the assessment of cardiovascular health and risk factors for heart disease. Cardio Risk Group: This group focuses on assessing various markers associated with cardiovascular health and risk factors, aiding in the early detection and management of cardiovascular diseases. Cognitive Health Group: This group of tailored tests is aimed at evaluating cognitive function and assessing markers related to cognitive health, providing valuable insights for cognitive well-being and potential cognitive disorders. Complete Cardiovascular Group: This group contains comprehensive tests for an extensive evaluation of cardiovascular health, providing thorough insights into heart-related conditions beyond basic assessments. Complete Lipid Group: Extensive tests offer a comprehensive evaluation of lipid levels, providing detailed insights into cholesterol and triglyceride profiles and their implications for cardiovascular health. Female Health Group: A comprehensive array of tests provides insights into various aspects of female health and wellness, aiding in the evaluation and management of overall health for females. Male Health Group: A comprehensive array of tests provides insights into various aspects of male health and wellness, aiding in the evaluation and management of overall health for men.
Optimal Range
For All Individuals:
Conventional Unit: < 100.00 mg/dL
SI Unit: < 1.13 mmol/L
Normal Range
For All Individuals:
Conventional Unit: < 150.00 mg/dL
SI Unit: < 1.69 mmol/L
Results That Differ From The Norm (Direct and Indirect Causes)
Increased levels may indicate:
Alcoholism
Chronic kidney disease
Crohn's disease (Chronic inflammation of the digestive tract)
Familial chylomicronemia syndrome (Inherited disorder affecting fat metabolism)
High-refined carbohydrates intake
Hypothyroidism (Underactive thyroid gland)
Low ...
Key Reasons For Testing
Cardiovascular Risk Assessment: Elevated triglycerides indicate increased risk of heart disease, coronary artery disease, and stroke.
Lipid Profile Evaluation: Provides comprehensive insights into lipid metabolism and cardiovascular risk when combined with cholesterol levels.
Metabolic Syndrome Diagnosis: High triglycerides aid in diagnosing metabolic syndrome, a cluster of conditions associated with increased risk.
Pancreatitis Risk Assessment: Identifies excessive triglyceride levels linked to an elevated risk of pancreatitis.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Pradhan AD, Glynn RJ, Fruchart JC, et al. Triglyceride lowering with pemafibrate to reduce cardiovascular risk. N Engl J Med. 2022;387(21):1923-1934.
[2] Varbo A, Benn M, Tybjaerg-Hansen A, et al. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol. 2013;61(4):427-436.
[3] Silbernagel G, Scharnagl H, Kleber ME, et al. LDL triglycerides, hepatic lipase activity, and coronary artery disease: an epidemiologic and Mendelian randomization study. Atherosclerosis. 2019;282:37-44.
[4] Hirano T. No change in small low-density lipoprotein cholesterol levels with pemafibrate might explain the negative results of the PROMINENT trial. J Diabetes Investig. 2023;14(4):630-631.
[5] Saeed A, Feofanova EV, Yu B, et al. Remnant-like particle cholesterol, low-density lipoprotein triglycerides, and incident cardiovascular disease. J Am Coll Cardiol. 2018;72(2):156-169.
[6] Marz W, Scharnagl H, Winkler K, et al. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease. Circulation. 2004;110(19):3068-3074.
[7] Jacobson TA, Maki KC, Orringer CE, et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 2. J Clin Lipidol. 2015;9(6).e1.
[8] Laufs U, Parhofer KG, Ginsberg HN, Hegele RA. Clinical review on triglycerides. Eur Heart J. 2020;41(1):99-109c.
[9] Quispe R, Martin SS, Michos ED, et al. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. Eur Heart J. 2021;42(43):4324-4332.
[10] Boren J, Williams KJ. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity. Curr Opin Lipidol. 2016;27(5):473-483.
[11] Fan W, Philip S, Granowitz C, et al. Residual hypertriglyceridemia and estimated atherosclerotic cardiovascular disease risk by statin use in U.S. adults with diabetes: National Health and Nutrition Examination Survey 2007-2014. Diabetes Care. 2019;42(12):2307-2314.
[12] Carroll MD, Kit BK, Lacher DA. Trends in elevated triglyceride in adults: United States, 2001–2012. NCHS Data Brief. 2015;(198):1-8.
[13] Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2019;74(10):1376-1414.
[14] Maki KC, Bays HE, Orringer CE, et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 27 randomised trials. Lancet. 2015;385(9976):1397-1405.
[15] Nordestgaard BG, Wootton R, Lewis B. Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Arterioscler Thromb Vasc Biol. 1995;15(4):534-542.
[16] Pradhan A, Paynter N, Glynn R, et al. ACCORD trial: Fenofibrate therapy did not reduce cardiovascular event rates in high triglyceride and low HDL subgroups. Am Heart J. 2010;160(1):56-62.